国际口腔医学杂志

国际口腔医学杂志 ›› 2019, Vol. 46 ›› Issue (5): 585-592.doi: 10.7518/gjkq.2019068

• 综述 • 上一篇    下一篇

头颈部鳞状细胞癌第二原发癌的研究进展

郝福1,孙睿1,2()   

  1. 1. 山西医科大学口腔医学院?口腔医院 太原 030001;
    2. 山西省人民医院口腔颌面外科 太原 030012
  • 收稿日期:2018-12-26 修回日期:2019-03-29 出版日期:2019-09-01 发布日期:2019-09-10
  • 通讯作者: 孙睿
  • 作者简介:郝福,住院医师,硕士,Email： 283425020@qq.com
  • 基金资助:
    山西省自然科学基金(2011011037-2)

Research progress on second primary carcinoma of head and neck squamous cell carcinoma

Hao Fu1,Sun Rui1,2()   

  1. 1. Dept. of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Shanxi Medical University, Taiyuan 030001, China
    2. Dept. of Oral and Maxillofacial Surgery, Shanxi Provincial People’s Hospital, Taiyuan 030012, China
  • Received:2018-12-26 Revised:2019-03-29 Online:2019-09-01 Published:2019-09-10
  • Contact: Rui Sun
  • Supported by:
    This study was supported by Program for Science Foundation of Shanxi Province(2011011037-2)

RichHTML

13

PDF (PC)

185

摘要：

头颈部鳞状细胞癌（HNSCC）是一种常见的致死性疾病,术后第二原发癌（SPC）形成是导致其远期生存率下降的主要原因之一。SPC发生不仅与吸烟、嗜酒、咀嚼槟榔等危险因素有关,而且与致癌物代谢、DNA修复、细胞周期和细胞凋亡等多个生物学过程相关蛋白表达异常和相关基因多态性导致的遗传易感性增加有关。因此,掌握SPC发生的危险因素和分子机制对于筛选SPC的高危人群和制定恰当的治疗方案具有重要的临床意义。

关键词: 头颈部鳞状细胞癌, 第二原发癌, 危险因素, 分子机制

Abstract:

Head and neck squamous cell carcinoma (HNSCC) is a common lethal disease, in which the formation of postoperative second primary carcinoma (SPC) mainly causes the decline of long-term survival rate. The occurrence of SPC is related to smoking, alcohol consumption, betel nut chewing, and other risk factors. Furthermore, SPC also involves the abnormal expression of related proteins and increase in genetic susceptibility caused by genetic polymorphisms in carcinogen metabolism, DNA repair, cell cycle, and apoptosis. Therefore, mastering the risk factors and molecular mechanisms of SPC is highly important in screening high-risk populations of SPC and in protocol development.

Key words: head and neck squamous cell carcinoma, second primary carcinoma, risk factor, molecular mechanism

中图分类号: 

  • R739.81
[1] Adjei Boakye E, Buchanan P, Hinyard L , et al. Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma[J]. JAMA Otolaryngol Head Neck Surg, 2018,144(8):727-737.
[2] Gutiérrez VF, Marcos CÁ, Llorente JL , et al. Genetic profile of second primary tumors and recurrences in head and neck squamous cell carcinomas[J]. Head Neck, 2012,34(6):830-839.
[3] Liao CT, Wallace CG, Lee LY , et al. Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area[J]. Oral Oncol, 2014,50(8):721-731.
[4] Koo K, Barrowman R , McCullough M, et al. Non-smoking non-drinking elderly females: a clinically distinct subgroup of oral squamous cell carcinoma patients[J]. Int J Oral Maxillofac Surg, 2013,42(8):929-933.
[5] Liao LJ, Chou HW, Wang CT , et al. The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study[J]. PLoS One, 2013,8(4):e62116.
[6] Li FL, Sturgis EM, Zafereo ME , et al. P73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck[J]. Int J Cancer, 2009,125(11):2660-2665.
[7] Zhang Y, Sturgis EM, Huang ZG , et al. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck[J]. Cancer, 2012,118(2):485-492.
[8] Zafereo ME, Sturgis EM, Aleem S , et al. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck[J]. Cancer Prev Res (Phila), 2009,2(5):432-439.
[9] Rettori MM, de Carvalho AC, Longo AL , et al. TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors[J]. J Transl Med, 2013,11:316.
[10] de Carvalho AC, Kowalski LP, Campos AH , et al. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients[J]. Oral Oncol, 2012,48(3):240-248.
[11] Lei DP, Sturgis EM, Liu ZS , et al. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck[J]. Carcinogenesis, 2010,31(2):222-227.
[12] Wang ZQ, Sturgis EM, Zhang FH , et al. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck[J]. Mol Cancer, 2012,11:17.
[13] Wu XF, Zhao H, Do KA , et al. Serum levels of insulin growth factor (IGF-I) and IGF-Binding protein predict risk of second primary tumors in patients with head and neck cancer[J]. Clin Cancer Res, 2004,10(12 Pt 1):3988-3995.
[14] Sun Y, Yu WB, Sturgis EM , et al. Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck[J]. BMC Cancer, 2016,16:70.
[15] Jin L, Sturgis EM, Zhang Y , et al. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck[J]. Carcinogenesis, 2013,34(7):1551-1557.
[16] Homann N, Nees M, Conradt C , et al. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma[J]. Clin Cancer Res, 2001,7(2):290-296.
[17] Tunca B, Erisen L, Coskun H , et al. P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck[J]. Tumori, 2007,93(2):182-188.
[18] Warren S, Gates O . Multiple primary malignant tumors: a survey of the literature and statistical study[J]. Am J Cancer, 1932,16(1):1358-1414.
[19] Braakhuis BJ, Tabor MP, Leemans CR , et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions[J]. Head Neck, 2002,24(2):198-206.
[20] Hong WK, Lippman SM, Itri LM , et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck[J]. N Engl J Med, 1990,323(12):795-801.
[21] Gleber-Netto FO, Braakhuis BJ, Triantafyllou A , et al. Molecular events in relapsed oral squamous cell carcinoma: recurrence vs. secondary primary tumor[J]. Oral Oncol, 2015,51(8):738-744.
[22] Montebugnoli L, Leonardi E, Morandi L , et al. Genetic relationship between multiple squamous cell carcinomas arising in the oral cavity[J]. Head Neck, 2014,36(1):94-100.
[23] Tirelli G, Zacchigna S, Biasotto M , et al. Erratum to: open questions and novel concepts in oral cancer surgery[J]. Eur Arch Otorhinolaryngol, 2016,273(8):1987-1988.
[24] Patrucco MS, Aramendi MV . Prognostic impact of second primary tumors in head and neck cancer[J]. Eur Arch Otorhinolaryngol, 2016,273(7):1871-1877.
[25] Bosetti C, Scelo G, Chuang SC , et al. High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries[J]. Int J Cancer, 2011,129(1):173-179.
[26] Yamamoto E, Shibuya H, Yoshimura R , et al. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma[J]. Cancer, 2002,94(7):2007-2014.
[27] Morris LG, Sikora AG, Patel SG , et al. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer[J]. J Clin Oncol, 2011,29(6):739-746.
[28] Ko HH, Cheng SL, Lee JJ , et al. Factors influencing the incidence and prognosis of second primary tumors in patients with oral squamous cell carcinoma[J]. Head Neck, 2016,38(10):1459-1466.
[29] Montebugnoli L, Gissi DB, Flamminio F , et al. Clinicopathologic parameters related to recurrence and locoregional metastasis in 180 oral squamous cell carcinomas[J]. Int J Surg Pathol, 2014,22(1):55-62.
[30] Farhadieh RD, Otahal P, Rees CG , et al. Radiotherapy is not associated with an increased rate of Second Primary Tumours in Oral Squamous Carcinoma: a study of 370 patients[J]. Oral Oncol, 2009,45(11):941-945.
[31] Huang SF, Li HF, Liao CT , et al. Association of HPV infections with second primary tumors in early-staged oral cavity cancer[J]. Oral Dis, 2012,18(8):809-815.
[32] Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López LA , et al. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria[J]. Med Oral Patol Oral Cir Bucal, 2010,15(6):e839-e845.
[33] Feng ZE, Xu QS, Qin LZ , et al. Second primary cancer after index head and neck squamous cell carcinoma in Northern China[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017,123(1):95-102.
[34] Wang L, Feng ZE, Wu HH , et al. Melanoma differentiation-associated Gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients[J]. Tumour Biol, 2014,35(11):10977-10985.
[35] Chohan TA, Qayyum A, Rehman K , et al. An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers[J]. Biomed Pharmacother, 2018,107:1326-1341.
[36] Laytragoon-Lewin N, Rutqvist LE, Lewin F . DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment[J]. Med Oncol, 2013,30(3):654.
[37] Kalfert D, Ludvikova M, Topolcan O , et al. Serum levels of IGF-1 and IGFBP-3 in relation to clinical and pathobiological aspects of head and neck squamous cell carcinomas[J]. Anticancer Res, 2017,37(6):3281-3286.
[38] Bowers LW, Rossi EL , O’Flanagan CH, et al. The role of the Insulin/IGF system in cancer: lessons learned from clinical trials and the energy balance-cancer link[J]. Front Endocrinol (Lausanne), 2015,6:77.
[39] Bongers V , Snow GB, de Vries N, et al. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor[J]. Lab Invest, 1995,73(4):503-510.
[40] Minard CG, Spitz MR, Wu XF , et al. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer[J]. Cancer, 2006,106(12):2636-2644.
[41] Jefferies S, Kote-Jarai Z, Goldgar D , et al. Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck[J]. Oral Oncol, 2005,41(5):455-461.
[42] Zhang QC, Xu HL, You YW , et al. High Gpx1 expression predicts poor survival in laryngeal squamous cell carcinoma[J]. Auris Nasus Larynx, 2018,45(1):13-19.
[43] Lei DP, Sturgis EM, Wang L , et al. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck[J]. Cancer Epidemiol Biomarkers Prev, 2010,19(6):1484-1491.
[44] Rehman S, Saba N, Naz M , et al. Single-nucleotide polymorphisms of FAS and FASL genes and risk of idiopathic aplastic anemia[J]. Immunol Invest, 2018,47(5):484-491.
[45] Escher A, Piotet E, Waridel F , et al. p53 mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients[J]. Eur Arch Otorhinolaryngol, 2009,266(4):547-551.
[46] Boscolo-Rizzo P . p53 mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients[J]. Eur Arch Otorhinolaryngol, 2009,266(3):465-466.
[47] Daher T, Tur MK, Brobeil A , et al. Combined Human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma[J]. Head Neck, 2018,40(6):1109-1119.
[48] Li FL, Sturgis EM, Chen XM , et al. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck[J]. Cancer, 2010,116(10):2350-2359.
[49] Zhang Y, Sturgis EM, Zafereo ME , et al. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck[J]. Cancer, 2011,117(6):1227-1235.
[50] Merolla F, Mascolo M, Ilardi G , et al. Nucleotide excision repair and head and neck cancers[J]. Front Biosci (Landmark Ed), 2016,21:55-69.
[51] Zafereo ME, Sturgis EM, Liu ZS , et al. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck[J]. Carcinogenesis, 2009,30(6):997-1002.
[52] Zhu YM, Yang HS, Chen Q , et al. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms[J]. DNA Repair (Amst), 2008,7(2):141-148.
[53] Gal TJ, Huang WY, Chen C , et al. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients[J]. Laryngoscope, 2005,115(12):2221-2231.
[1] 刘世一, 陈中, 张素欣. 程序性死亡受体/配体免疫治疗策略在人乳头瘤病毒阳性头颈部鳞状细胞癌中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 21-27.
[2] 王楠楠,贺红,花放. 正畸相关釉质脱矿危险因素的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 91-98.
[3] 李奕君, 徐子昂, 李一. 前哨淋巴结在头颈部鳞状细胞癌检测的应用进展[J]. 国际口腔医学杂志, 2023, 50(5): 521-527.
[4] 王婧妍,秦满,王欣. Axenfeld-Rieger综合征的口腔颌面部临床特点及相关成对同源结构域转录因子2基因突变的致病机制研究进展[J]. 国际口腔医学杂志, 2023, 50(2): 224-229.
[5] 李洪芳,陈中,张素欣. 免疫检查点抑制剂联合放射治疗在头颈部鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(5): 614-620.
[6] 郝一龙,周瑜,陈谦明. 正中菱形舌炎发病危险因素的研究进展[J]. 国际口腔医学杂志, 2019, 46(3): 333-338.
[7] 毛璐,鞠侯雨,任国欣. 程序性细胞死亡受体-1与其配体信号通路的调控及其在头颈鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2018, 45(5): 560-565.
[8] 黄艳丽，郭维华，田卫东. 糖尿病前期和牙周炎的相互关系[J]. 国际口腔医学杂志, 2016, 43(6): 706-710.
[9] 哈茜 陆海霞 冯希平. 出生队列研究在口腔医学中的应用[J]. 国际口腔医学杂志, 2016, 43(5): 549-553.
[10] 陈甜,白丁. 骨硬化蛋白对牙骨质形成的影响及其机制[J]. 国际口腔医学杂志, 2016, 43(3): 333-337.
[11] 袁昌青，耿国梁，姜文静，徐全臣，董静，邓婧，孙培. 原发性干燥综合征患者萎缩性舌炎发病情况及相关因素研究[J]. 国际口腔医学杂志, 2015, 42(5): 553-556.
[12] 姜曚 张玲综述 李继遥 柳茜审校. 口腔医生的骨骼肌肉系统疾病研究进展[J]. 国际口腔医学杂志, 2013, 40(2): 249-252.
[13] 王艳综述 周学东审校. 牙周炎与高血压关系的研究进展[J]. 国际口腔医学杂志, 2012, 39(5): 664-667.
[14] 刘勇 杨荣涛综述 李祖兵审校. 梅克尔软骨消亡的分子机制研究进展[J]. 国际口腔医学杂志, 2012, 39(3): 339-341.
[15] 李杨, 张晔, 邹静, 尹菁菁, 康德英. 厦门市3~6 岁儿童患龋危险因素分析[J]. 国际口腔医学杂志, 2009, 36(6): 635-638，642.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 王昆润. 二甲亚砜和双氯芬酸并用治疗根尖周炎[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 汤庆奋,王学侠. 17β-雌二醇对人类阴道和口腔颊粘膜的渗透性[J]. 国际口腔医学杂志, 1999, 26(06): .
[3] 潘劲松. 颈总动脉指压和颈内动脉球囊阻断试验在大脑血液动力学中的不同影响[J]. 国际口腔医学杂志, 1999, 26(05): .
[4] 王昆润. 后牙冠根斜形牙折的治疗[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 杨锦波. 嵌合体防龋疫苗的研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 王昆润. 下颔骨成形术用网状钛板固定植骨块[J]. 国际口腔医学杂志, 1999, 26(04): .
[7] 汪月月,郭莉莉. 口腔机能与老化—痴呆危险因素流行病学研究[J]. 国际口腔医学杂志, 1999, 26(04): .
[8] 丁刚. 应用硬组织代用品种植体行丰颏术[J]. 国际口腔医学杂志, 1999, 26(04): .
[9] 田磊. 局部应用脂多糖后结合上皮反应性增生的变化[J]. 国际口腔医学杂志, 1999, 26(04): .
[10] 戴青. 口腔念珠菌病的新分类[J]. 国际口腔医学杂志, 1999, 26(04): .